Chaudhari, IN
Ajay Chaudhari, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20100268993 | DISABLEMENT OF AN EXCEPTION GENERATING OPERATION OF A CLIENT SYSTEM - A method and system of disablement of an exception generating operation of a client system are disclosed. In an embodiment, a method is disclosed in which a snapshot of a client system is acquired. An execution of the client system is recorded, and a system wide exception is intercepted before it causes a client system crash. The execution of the client system is replayed from the snapshot of the client system, and an operation that generates the system wide exception is disabled. | 10-21-2010 |
Amit Chaudhari, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20160132622 | CONVERSION OF GEOMETRIC ENTITIES OF 1D ELEMENTS IN A FEM FROM A SOURCE FEA TOOL FORMAT TO A DESTINATION FEA TOOL FORMAT - System and method of converting geometric entities of 1D elements in a finite element model (FEM) from a source finite element analysis (FEA) tool format to a destination FEA tool format is disclosed. In one embodiment, coordinates of all the geometric entities associated with each 1D element in the FEM are transformed from the source FEA tool format to a global coordinate system. The geometric entities of the ID elements in the FEM are then converted from the source FEA tool format to the destination FEA tool format using the transformed coordinates of all the geometric entities associated with each 1D element. | 05-12-2016 |
Anita Chaudhari, Gandhinagar IN
Patent application number | Description | Published |
---|---|---|
20110130414 | NOVEL FUSED THIAZOLO AND OXAZOLO PYRIMIDINONES - The present invention relates to novel compounds, their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals. | 06-02-2011 |
20130331406 | NOVEL FUSED THIAZOLO AND OXAZOLO PYRIMIDINONES - The present invention relates to novel compounds, their pharmaceutically acceptable salts, and their isomers, steroisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals. | 12-12-2013 |
20150126530 | Novel Substituted Imidazopyrimidines as Gpbar1 Receptor Modulators - The present invention relates to novel substituted imidazo[1,2-a]pyrimidine compounds of formula (I), their pharmaceutically acceptable salts, and their isomers, stereoisomers, conformers, tautomers, polymorphs, hydrates and solvates. The present invention also encompasses pharmaceutically acceptable compositions of said compounds and process for preparing novel compounds. The invention further” relates to the use of the above-mentioned compounds for the preparation of medicament for use as pharmaceuticals. (Formula I). | 05-07-2015 |
Ashok Tukaram Chaudhari, Bhosari IN
Patent application number | Description | Published |
---|---|---|
20150232467 | PYRIDONE DERIVATIVES AS ACID SECRETION INHIBITORS AND PROCESS FOR PREPARATION THEREOF - The present invention relates to the preparation of stable pyridone disulphide derivatives having general formula (I) and its stereoisomers, which are useful in the treatment of gastrointestinal disorders. Pyridone disulphide derivatives (I) wherein, R | 08-20-2015 |
Bapu Atmaram Chaudhari, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20130053579 | PROCESS FOR THE PREPARATION OF N-METHYL-O-ARYLOXY PROPANAMINE DERIVATIVES AND PHARMACEUTICALLY ACCEPTABLE SALT THEREOF - A process for the preparation on N-methyl-aryloxy-propanamine derivatives of the formula I and salts thereof. The invention also relates to the preparation and use novel intermediate of the formula XII. The invention also relates to the process of further conversion of novel intermediate into N-methyl-aryloxy propanamine derivatives and salts thereof. | 02-28-2013 |
Ganesh Chaudhari, Ahemdnagar IN
Patent application number | Description | Published |
---|---|---|
20160052919 | PROCESS FOR THE PREPARATION OF RIVAROXABAN - Disclosed is a process for the preparation of rivaroxaban and purifying rivaroxaban. | 02-25-2016 |
Harshal Dilip Chaudhari, Pune (maharashtra) IN
Patent application number | Description | Published |
---|---|---|
20140017595 | PROCESS FOR THE PREPARATION OF MEMBRANE ELECTRODE ASSEMBLIES (MEAs) - PBI-based MEAs for high temperature Polymer Electrolyte Membrane Fuel Cell (PEMFC) were prepared by direct hot pressing of catalyst layer on Teflon sheets on to both sides of phosphoric acid doped PBI membrane (decal transfer). These MEAs show two times higher performance compared to the MEAs prepared by normal brush coating method on GDL at an operating temperature of 160° C. | 01-16-2014 |
Hemant Chaudhari, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20100036129 | PROCESS FOR THE PREPARATION OF IMIDAZOPYRIDINES - A process for the preparation of imidazopyridines of formula (I), comprising reacting 6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine with oxalyl chloride, followed by conversion of the chloride to oxoacetic acid, and further to compound of Formula (I). | 02-11-2010 |
Mahendra Chaudhari, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20080220060 | Gastroretentive Formulations and Manufacturing Process Thereof - The present invention concerns gastroretentive formulation comprising an active substance granulated with a mixture of a weak gelling agent, a strong gelling agent, and a gas generating agent and process for manufacturing said formulation. | 09-11-2008 |
Mahendra B. Chaudhari, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20080248111 | Orodispersible Tablets of Bitter Active Principles - The invention concerns coated granules including (A) at least one amine-containing pharmacological active principle, preferably as an acid addition salt, the pharmacological active principle being complexed by low cation-exchange resin containing carboxylic acid groups (COO″), and (B) at least 15 wt. %, based on the total weight of the active principle/low cation-exchange resin complex, of at least one hydrophilic adsorbent, the mixture of the components (A) and (B) being coated with a gastrosoluble polymer. The invention also concerns a method for preparing such granules, as well as orodispesible tablets containing such granules. | 10-09-2008 |
Mahesh Chaudhari, Jalgaon IN
Patent application number | Description | Published |
---|---|---|
20080265176 | COMPOSITION, METHOD OF AUTHENTICATING, METHODS OF MAKING AUTHENTICATABLE COMPOSITIONS, AUTHENTICATABLE ARTICLES MADE THERE FROM - A composition comprising compound of formula I, a process for preparing the composition comprising compound of formula I, methods of authentication for an article comprising compound of formula I or compound of formula II, authentication technology for polymer based articles comprising compound of formula I or formula II, methods of facilitating such authentication and method of making articles capable of authentication. | 10-30-2008 |
Mahesh Kisan Chaudhari, Jalgaon IN
Patent application number | Description | Published |
---|---|---|
20090081560 | COMPOSITIONS AND METHODS FOR STORING HOLOGRAPHIC DATA - The present invention provides a method for storing holographic data comprising providing a holographic storage medium comprising an optically transparent substrate including a photochemically active dye having at least two nitrone groups; and irradiating the optically transparent substrate with a holographic interference pattern, wherein the pattern has a first wavelength and an intensity both sufficient to convert, within a volume element of the substrate, at least some of the photochemically active dye into a photo-product, and producing within the irradiated volume element concentration variations of the photo-product corresponding to the holographic interference pattern, thereby producing a first optically readable datum corresponding to the volume element. | 03-26-2009 |
20090082580 | COMPOSITIONS AND METHODS FOR STORING HOLOGRAPHIC DATA - In one aspect, the present invention provides a novel thiophene-containing polynitrone compound having structure (II) | 03-26-2009 |
Namrata Anil Chaudhari, Maharahstra IN
Patent application number | Description | Published |
---|---|---|
20120029185 | NOVEL INTERMEDIATES IN THE PREPARATION OF 1,4-DIPHENYL AZETIDINONE - The process of the present invention relates to a method for the synthesis of a 1,4-diphenylazetidinone of formula (VIII) by using novel oxime intermediates. | 02-02-2012 |
Narendra P. Chaudhari, Navi Mumbai IN
Patent application number | Description | Published |
---|---|---|
20090298907 | METHOD FOR THE PREPARATION OF 4-FLUORO-ALPHA-[2-METHYL-1-OXOPROPYL]-y-OXO-N-BETA-DIPHENYLBENZENEBUTANAM- IDE AND PRODUCTS THEREFROM - A method for the preparation of 4-fluoro-α-[2-methyl-1-oxopropyl]-y-oxo-N-β-diphenylbenzenebutanamide also known as 2-[2-(4-fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-pentanoic acid phenylamide of the formula I containing about 0.1% or less of α-[2-methyl-1-oxopropyl]-γ-oxo-N-p-diphenylbenzene butanamide, about 0.05% or less of difluoro-α-[2-methyl-1-oxopropyl]-y-oxo-N-β-diphenylbenzene butanamide and about 0.1% or less of 3-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethoxy]-4-methyl-pent-2-enoic acid phenylamide. | 12-03-2009 |
20110060164 | METHOD FOR THE PREPARATION OF 4-FLUORO-ALPHA-[2-METHYL-1-OXOPROPYL]-GAMMA-OXO-N-BETA-DIPHENYLBENZENEBUT- ANAMIDE AND PRODUCTS THEREFROM - A method for the preparation of 4-fluoro-α-[2-methyl-1-oxopropyl]-γ-oxo-N-β-diphenylbenzenebutanamide also known as 2-[2-(4-fluorophenyl)-2-oxo-1-phenylethyl]-4-methyl-3-oxo-pentanoic acid phenylamide of the formula I containing about 0.1% or less of α-[2-methyl-1-oxopropyl]-γ-oxo-N-β-diphenylbenzene butanamide, about 0.05% or less of difluoro-α-[2-methyl-1-oxopropyl]-γ-oxo-N-β-diphenylbenzene butanamide and about 0.1% or less of 3-[2-(4-Fluorophenyl)-2-oxo-1-phenyl-ethoxy]-4-methyl-pent-2-enoic acid phenylamide. | 03-10-2011 |
Nilendra Chaudhari, Navi Mumbai IN
Patent application number | Description | Published |
---|---|---|
20160132913 | Multivariate Canonical Data Model for Tagging Customer Base of Energy Utility Enterprise - A system and method contact a customer of an energy utility to solicit participation in an energy efficiency, sustainability, or reliability program. The system receives data pertaining to each customer, the data for each customer having a plurality of attributes pertaining to a customer descriptive characteristic, communications history, energy usage, or attitude. The data are normalized to a canonical form, and populated in a multivariate data model. Data in the model is clustered using a multivariate algorithm. Each cluster is assigned a utility customer segment, such as “Concerned Green” or “DIY”, that reflects the prevalent attributes. For each segment, the system determines a prospect subset of the customers most likely to participate in an offering pertaining to that segment according to a likelihood threshold. Finally, a prospect customer is contacted with an offering that may be customized according to the assigned customer segment. | 05-12-2016 |
Rajendra Pralhad Chaudhari, Mumbai IN
Patent application number | Description | Published |
---|---|---|
20110045978 | HERBICIDAL FORMULATION - This invention relates to an improved granular formulation of herbicide glyphosate in form of ammonium salt using environmentally friendly adjuvants, and a process for preparation thereof. The formulation minimizes the use of some inactive ingredients without compromising the effectiveness of the product. | 02-24-2011 |
Rajendra Yashwant Chaudhari, Thane (west) IN
Patent application number | Description | Published |
---|---|---|
20150353737 | CURABLE TWO-PART COATINGS FOR CONDUCTORS - A compositional kit for forming a composition includes a first composition and a second composition which are separate. The first composition includes a filler, a cross-linking agent and an emissivity agent; and the second composition includes a silicate binder. Methods for making a compositional kit and for making a coated overhead conductor are also provided. | 12-10-2015 |
20160032107 | CURABLE TWO-PART COATINGS FOR CONDUCTORS - A compositional kit for forming a composition includes a first composition and a second composition which are separate. The first composition includes a filler, a cross-linking agent and an emissivity agent; and the second composition includes a silicate binder. Methods for making a compositional kit and for making a coated overhead conductor are also provided. | 02-04-2016 |
Sachin Sundarial Chaudhari, Navi Mumbai IN
Patent application number | Description | Published |
---|---|---|
20120115886 | FUSED PYRIMIDINEONE COMPOUNDS AS TRPV3 MODULATORS - The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. | 05-10-2012 |
Sachin Sundarlal Chaudhari, Navi Mumbai IN
Patent application number | Description | Published |
---|---|---|
20090286811 | FUSED PYRIMIDINEONE COMPOUNDS AS TRPV3 MODULATORS - The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. | 11-19-2009 |
20100152192 | FUSED IMIDAZOLE CARBOXAMIDES AS TRPV3 MODULATORS - The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. | 06-17-2010 |
20110237659 | CHROMENONE DERIVATIVES AS TRPV3 ANTAGONISTS - The present invention provides transient receptor potential vanilloid (TRPV) modulators of formula (I). In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. | 09-29-2011 |
20120041004 | FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPAI MODULATORS - The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 02-16-2012 |
20120108813 | FUSED PYRIMIDINEONE COMPOUNDS AS TRPV3 MODULATORS - The present invention provides transient receptor potential vanilloid (TRPV) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPV3. | 05-03-2012 |
20120157411 | 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AS TRPAI ANTAGONISTS - The present invention is related to 2-amino-4-arylthiazole derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 06-21-2012 |
20120178766 | FUROPYRIMIDINEDIONE DERIVATIVES AS TRPAI MODULATORS - The present invention is related to novel furopyrimidinedione derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 07-12-2012 |
20120316136 | TREATMENT OF RESPIRATORY DISORDERS USING TRPA1 ANTAGONISTS - The present patent application relates to treatment of a respiratory disorder using TRPA1 antagonists. Particularly, the present patent application relates to treatment of a respiratory disorder using a TRPA1 antagonist, wherein the TRPA1 antagonist is administered by inhalation route to a subject in need thereof. | 12-13-2012 |
20140045865 | 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AS TRPA1 ANTAGONISTS - The present invention is related to 2-amino-4-arylthiazole derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 02-13-2014 |
20140051667 | 2-AMINO-4-ARYLTHIAZOLE COMPOUNDS AS TRPA1 ANTAGONISTS - The present invention is related to 2-amino-4-arylthiazole derivatives as TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). Also provided herein are processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 02-20-2014 |
20140128603 | FUSED PYRIMIDINE-DIONE DERIVATIVES AS TRPA1 MODULATORS - The invention described herein relates to novel fused pyrimidinediones derivatives of formula (I) which are TRPA (Transient Receptor Potential subfamily A) modulators. In particular, compounds described herein are useful for treating or preventing diseases, conditions and/or disorders modulated by TRPA1 (Transient Receptor Potential subfamily A, member 1). This invention also provides processes for preparing compounds described herein, intermediates used in their synthesis, pharmaceutical compositions thereof, and methods for treating or preventing diseases, conditions and/or disorders modulated by TRPA1. | 05-08-2014 |
Shrikant S. Chaudhari, Maharasthra IN
Patent application number | Description | Published |
---|---|---|
20080305158 | Methods For the Preparation of Stable Pharmaceutical Solid Dosage Forms of Atorvastatin and Amlodipine - The present invention relates to pharmaceutical compositions comprising amlodipine and pharmaceutically acceptable salts thereof, and atorvastatin and pharmaceutically acceptable salts thereof, and processes for their preparation. | 12-11-2008 |
Sneha S. Chaudhari, Pune IN
Patent application number | Description | Published |
---|---|---|
20150032508 | Systems And Methods For Probing Customers And Making Offers In An Interactive Setting - Methods and systems for recommending a product to a customer based on the customer's responses to a prioritized list of questions. A list of questions to ask the customer is created based on stored customer identifiers. The list of questions is priorities based on a pre-existing propensity score associated with the customer, and the agent asks the ranked questions. Based on the response of the customer, the propensity score and/or the list of questions is updated, and the agent is presented with a recommended product to suggest to the customer. | 01-29-2015 |
Sudhir Ramesh Chaudhari, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120000168 | INLET AIR FILTRATION SYSTEM - Embodiments of the present invention provide an inertial filtration system for air-ingesting machines. The inertial filter | 01-05-2012 |
Sunil Chaudhari, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20130203778 | PHARMACEUTICAL COMPOSITION COMPRISING A PYRIMIDINEONE DERIVATIVE - The present patent application relates to a pharmaceutical composition comprising a fused pyrimidineone derivative having transient receptor potential modulating activity and a hydrophilic carrier. | 08-08-2013 |
Sunil Sudhakar Chaudhari, Maharashtra IN
Patent application number | Description | Published |
---|---|---|
20100068284 | Stable Fixed Dose Topical Formulation - The present invention relates to stable fixed dose topical formulations comprising an antiacne agent and an antibiotic, which exhibit storage stability at a temperature of about 40° C. and relative humidity of about 75% for a period of at least 3 months. Particularly, the present invention relates to stable fixed dose topical formulations comprising therapeutically effective amounts of (a) adapalene-containing microspheres and (b) clindamycin, a process for their preparation thereof and their use for the treatment of acne. | 03-18-2010 |
Sunil Sudhakar Chaudhari, Nashik IN
Patent application number | Description | Published |
---|---|---|
20130028977 | PHARMACEUTICAL POWDER COMPOSITION FOR INHALATION - The present invention relates to a pharmaceutical powder composition for inhalation comprising an active ingredient and a pharmaceutically acceptable carrier, process for preparing such composition, and its use for the treatment of respiratory disorder in a subject. | 01-31-2013 |
20140377358 | NANOPARTICULATE FORMULATION COMPRISING A TRPA1 ANTAGONIST - The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor (“TRPA1”) antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer; a process for preparing such formulation; and its use in treating a respiratory disorder or pain in a subject. | 12-25-2014 |
Sushil Chaudhari, Raebareli IN
Patent application number | Description | Published |
---|---|---|
20120173675 | METHOD AND SYSTEM FOR DISPLAYING MULTIMEDIA SERVICES FROM A SERVER TO MULTIPLE CLIENTS - A method and system for displaying multimedia services from a server to multiple clients is provided. The method includes transmitting control information from the server to one or more clients. The method also includes assigning a channel to the one or more of the clients. The method further includes transmitting display information to the one or more clients, using the channel. The method additionally includes receiving update information from the one or more clients using a back channel. Moreover, the method includes modifying the update information received by the server and transmitting the update information to the one or more clients using a forward channel. The system includes a server and one or more clients. | 07-05-2012 |
Tansen Dhananjay Chaudhari, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20090148665 | NANO-CELLULAR POLYMER FOAM AND METHODS FOR MAKING THEM - A nano-cellular polymer foam is disclosed, which has an average pore size from about 10 nanometers to about 500 nanometers; and a foam density that is from about 1 percent to about 50 percent of the bulk density of the material of the nano-cellular foam. | 06-11-2009 |
Vinod Chaudhari, Bangalore IN
Patent application number | Description | Published |
---|---|---|
20120165331 | Di/tri-aza-spiro-C9-C11alkanes - The invention relates to compounds of the formula I | 06-28-2012 |
20120264748 | DIAZA-SPIRO[5.5]UNDECANES - The invention relates to compound of the formula (I), in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it. | 10-18-2012 |
Vinod Chaudhari, Pune IN
Patent application number | Description | Published |
---|---|---|
20120258973 | DISUBSTITUTED HETEROARYL-FUSED PYRIDINES - The invention relates to compound of the formula (I′) in which the substituents are as defined in the specification; in free form or in salt form; to its preparation, to its use as medicament and to medicaments comprising it. | 10-11-2012 |
Vinod Dinkar Chaudhari, Pune IN
Patent application number | Description | Published |
---|---|---|
20130345213 | SUBSTITUTED MORPHOLINES AS MODULATORS FOR THE CALCIUM SENSING RECEPTOR - Compounds of Formula (I) along with processes for their preparation that are useful for treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (CaSR) receptors. Methods of treating, managing and/or lessening the diseases, disorders, syndromes or conditions associated with the modulation of calcium sensing (CaSR) receptors of Formula (I). | 12-26-2013 |
20150239827 | ARYLALKYLAMINE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS - The present invention provides arylalkylamine compounds as calcium sensing receptor modulators (CaSR). In particular, the compounds described herein are useful for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of calcium sensing receptors (CaSR). The invention also provides herein the pharmaceutical compositions thereof, and methods for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of CaSR. The invention also relates to process for the preparation of the compounds of the invention. (Formula I) | 08-27-2015 |
20160075655 | ARYLALKYLAMINE COMPOUNDS AS CALCIUM SENSING RECEPTOR MODULATORS - The present invention provides arylalkylamine compounds as calcium sensing receptor modulators (CaSR). In particular, the compounds described herein are useful for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of calcium sensing receptors (CaSR). The invention also provides herein the pharmaceutical compositions thereof, and methods for treating, managing, and/or lessening the severity of diseases, disorders, syndromes and/or conditions associated with the modulation of CaSR. The invention also relates to process for the preparation of the compounds of the invention. (Formula I) | 03-17-2016 |